The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.